Cart
sales@molnova.com
BRD9526
CAS No. 1446352-30-2
BRD9526( BRD 9526 )
Catalog No. M11897 CAS No. 1446352-30-2
BRD9526 is a potent, small-molecule inhibitor of the Sonic Hedgehog (Shh) pathway with EC50 of 60 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1413 | Get Quote |
|
| 50MG | 2862 | Get Quote |
|
| 100MG | 3870 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBRD9526
-
NoteResearch use only, not for human use.
-
Brief DescriptionBRD9526 is a potent, small-molecule inhibitor of the Sonic Hedgehog (Shh) pathway with EC50 of 60 nM.
-
DescriptionBRD9526 is a potent, small-molecule inhibitor of the Sonic Hedgehog (Shh) pathway with EC50 of 60 nM, partially lowers Gli1 expression at concentrations of 10 uM, a useful probe of Shh signaling pathway.
-
In Vitro——
-
In Vivo——
-
SynonymsBRD 9526
-
PathwayGPCR/G Protein
-
TargetHedgehog (Hh)
-
RecptorHedgehog (Hh)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1446352-30-2
-
Formula Weight584.509
-
Molecular FormulaC26H31Cl2N3O6S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameCyclopropanecarboxamide, N-[(2R,3S)-2-[[[(2,4-dichlorophenyl)sulfonyl]methylamino]methyl]-3,4,5,6-tetrahydro-5-[(1R)-2-hydroxy-1-methylethyl]-3-methyl-6-oxo-2H-1,5-benzoxazocin-10-yl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Schaefer GI, et al. J Am Chem Soc. 2013 Jul 3;135(26):9675-80.
molnova catalog
related products
-
SMANT hydrochloride
SMANT hydrochloride is an antagonist of Smoothened accumulation.
-
SMO-IN-2
SMO-IN-2 is a potent smoothened (SMO) inhibitor of hedgehog (Hh) signaling.SMO-IN-2 shows antiproliferative activity and anticancer activity against human medulloblastoma cell lines.SMO-IN-2 can be used in the study of cancer.
-
Epiberberine
Epiberberine may be caused drug interactions based on CYP2D6 enzyme. Epiberberine has anti-adipogenic effect is mediated by downregulation of the Raf/MEK1/ERK1/2 and AMPKα/Akt pathways during 3T3-L1 adipocyte differentiation.
